Zealand Pharma says Phase 2 ZUPREME-1: petrelintide cuts weight up to 10.7% at 42 weeks

Zealand Pharma flagged Phase 2 ZUPREME-1 results for petrelintide in obesity; additional data are due at EASD 2026 and results will be presented on Sept 30, 2026 at 3:30 p.m. CEST.